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Abstract
Background: The bacteria Escherichia coli K4 produces a capsular polysaccharide (K4 CPS) whose backbone is
similar to the non sulphated chondroitin chain. The chondroitin sulphate is one of the major components of the
extra-cellular matrix of the vertebrate connective tissues and a high value molecule, widely employed as active
principle in the treatment of osteoarthritis. It is usually obtained by extraction from animal tissues, but the risk of
virus contaminations, as well as the scarceness of raw material, makes this productive process unsafe and unable to
satisfy the growing market demand. In previous studies a new biotechnological process to produce chondroitin
from Escherichia coli K4 capsular polysaccharide was investigated and a 1.4 g·L
-1 K4 CPS concentration was reached
using fed-batch fermentation techniques. In this work, on the trail of these results, we exploited new fermentation
strategies to further improve the capsular polysaccharide production.
Results: The inhibitory effect of acetate on the bacterial cells growth and K4 CPS production was studied in shake
flask conditions, while a new approach, that combined the optimization of the feeding profiles, the improvement
of aeration conditions and the use of a microfiltration bioreactor, was investigated in three different types of
fermentation processes. High polysaccharide concentrations (4.73 ± 0.2 g·L
-1), with corresponding average yields
(0.13 ± 0.006 gK4 CPS·gcdw
-1), were obtained; the increase of K4 CPS titre, compared to batch and fed-batch results,
was of 16-fold and 3.3-fold respectively, while average yield was almost 3.5 and 1.4 fold higher.
Conclusion: The increase of capsular polysaccharide titre confirmed the validity of the proposed fermentation
strategy and opened the way to the use of the microfiltration bioreactor for the biotechnological production of
chondroitin.
Background
Hyaluronic acid (HA), heparin (HS) and chondrotin sul-
phate (CS) are primary constituents of eukaryotic extra-
cellular matrix of connective tissues, involved in important
biological roles and in fundamental physiological processes
[1]; but these glycosaminoglycans (GAGs) have also
important pharmacological properties and numerous bio-
medical applications. GAGs are widely used as the active
principle of numerous drugs [2-4] and they are nowadays
considered high value molecules. They are traditionally
produced by extraction and purification from animal tis-
sue sources, such as rooster combs (HA), bovine trachea
or shark fins (CS) and pork intestinal mucosa (HS), by
using complex manufacturing processes that include
enzymes, acidic and/or alkaline treatments and organic
solvents [3,5]. The scarcity of raw materials (e.g. the shark
fin cartilage) and a very high risk of viral contaminations,
dangerous for human health, are the main disadvantages
of this extractive method of production. All these issues
may induce the regulatory officer to favour the introduc-
tion of novel biotechnological productive methods. For
these reasons in the last years new approaches based on
the use of microorganisms for the glycosaminoglycan pro-
duction were investigated in order to meet the growing
market demand, to solve the problems related to the
extractive production process and to satisfy the customer’s
expectation to have a safe product, free from any contami-
nations dangerous for health. Capsulated Gram-positive
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resemble vertebrate glyco-conjugate molecules, have
gained biotechnological research attention as potential
GAGs producers. Various wild type or genetically modi-
fied strains of group C of Streptococcus genera were
already employed for the biotechnological large scale pro-
duction of HA by using fermentation technologies; the
produced polysaccharide satisfies the market requests and
it is widely employed in pharmaceutical and cosmetic pro-
ducts [6]. Escherichia coli O5:K4:H4 produces a capsular
polysaccharide (K4 CPS) whose repeating disaccharide unit
is constituted by glucuronic acid and N-acetylgalactosamine
and that, except for a b-linked terminal furanose residue
of fructose, is similar to the non sulphated chondroitin
chain [7]. As we have already investigated in a previous
paper [8], the capsular polysaccharide could be biotechno-
logically produced using E. coli K4 bacteria, that synthesize
and release it in the culture medium during the growth.
As part of the cell wall, the capsular polysaccharide could
be considered a biomass related product, but its biosynth-
esis is strictly regulated by environmental and growth con-
ditions [7,8]. For these reasons, the achievement of high
biomass concentrations and the optimization of growth
parameters are the main targets to obtain high K4 CPS
yields for an efficient, economically reliable and indust-
rially advantageous biotechnological productive process.
High cell density cultivation techniques (HCDC) are com-
monly used in numerous manufacturing processes to
reach the cost effective production of desired products,
the primary goal of fermentation research [9]. The
research on high cell density cultivation techniques gener-
ally includes the optimization of the feeding and aeration
profiles during the fermentation process, the design of
bioreactors and the study of strategies to avoid the bio-
synthesis of growth inhibitory by-products. For example,
acetate accumulation is one of the obstacles in obtaining
high product yield and productivities in cultivation of
E. coli genus strains; this metabolic by-product is over-
produced when the up-take of carbon source is greater
than its conversion into biomass and CO2,o rw h e nt h e
carbon flux, into the central metabolic pathway, exceeds
the biosynthetic demand and the cell capacity to produce
energy. In these conditions a saturation of the tricarboxylic
acid cycle (TCA) and/or of the respiratory chain occurs
[10]. Thus acetate is synthesized under anaerobic condi-
tions but also under fully aerobic conditions in case of an
excess of carbon sources; these two mechanisms are often
referred to as mixed-acid fermentation and as overflow
metabolism. Modifying the medium composition, avoiding
carbon accumulation, improving the oxygen transfer capa-
city and controlling the feed rate are some of the biopro-
cess strategies used to avoid acetate accumulation; but
using low feeding profiles could give also low growth
rates, very low productivity and could not help in
obtaining high cell density cultivations. Removing
inhibiting by-products from the vessel during the fermen-
tation processes, instead, could be a helpful way to achieve
the challenge of keeping feed rates high. To reach this tar-
get various techniques have been studied and different
bioreactors have been designed and used also for E. coli
fermentation, like dialysis-fermentors or macroporous
ion-exchange resin devices [11-13].
Our research group developed a microfiltration (MF)
bioreactor in which two polymeric hollow fibre modules
were inserted in a fermentation vessel and were able to
remove low molecular weight inhibiting metabolites
without removing the cells. This reactor has been already
successfully employed in the growth of a recombinant
E. coli strain, expressing a heterologous a-glucosidase
from a thermophile bacteria or in the exopolysaccharides
production of probiotic lactic acid strains [14,15]. In a
previous paper we investigated the physiological condi-
tions of E. coli K4 growth and of the capsular polysac-
charide production, designing a balanced, nutrient and
economic medium, suitable for large scale industrial
applications. Lab-scale batch and fed-batch fermentation
experiments were performed, allowing us to test a real
possibility of a biotechnological production of CS from
the K4 CPS and to reach a polysaccharide concentration
of 1.4 g·L
-1 with a yield of 0.091 gK4 CPS·gcdw
-1 [8]. How-
ever in fed-batch experiments, after 22-24 hour feeding,
the E. coli K4 growth and thus K4 CPS production
seemed to be limited by acetate formation.
In this research, we investigated the E. coli K4 acetate
inhibiting threshold in shake flasks conditions and we
exploited the use of the microfiltration bioreactor for
the production of E. coli K4 capsular polysaccharide,
modulating the feeding and the aeration profiles in
order to obtain higher polysaccharide concentration and
production yield values.
Results
Shake flask experiments
In order to investigate the effect of acetate concentration
on the growth of E. coli K4 and its capsular polysacchar-
ide production ability, several shaking flask experiments
were performed by using eight different acetate concen-
trations in the medium, in the range from 0 to 40 g·L
-1.
No sensible changes in the growth medium initial pH
values were observed when acetate was added (from a
pH value of 7.42 ± 0.01 for 0 g·L
-1 to 7.35 ± 0.01 for
40 g·L
-1 of added acetate). Growth rates (μmax) calculated
during the exponential phase, showed a dependency on
the acetate concentrations: compared with the control
(without acetate the μmax μ=0 . 7 4 6±0 . 0 5 5 · h
-1), the addi-
tion of 1.5 g·L
-1 of acetate to the medium seemed to
slightly help bacterial replication increasing the μmax to
0.845 ± 0.017 h
-1 (Figure 1). A growth rate value similar
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tion of 5 g·L
-1 acetate (μmax μ= 0.795 ± 0.013 h
-1), while a
significant decrease in μmax (0.680 ± 0.022 h
-1)w a s
noticed when 10 g·L
-1 of acetate were added (Figure 1).
The capsular polysaccharide biosynthesis seemed to be
influenced by the acetate addition too (Figure 2). Com-
pared to the K4 CPS concentration in the conventional
medium (0.117 ± 0.01 g·L
-1) after 24 hours of growth, the
addition of 1.5 g·L
-1 of acetate caused an increase to
0.195 ± 0.02 g·L
-1 (Figure 2). Similarly to the control, in
this case, the whole glycerol amount was consumed dur-
ing the growth (data not shown). Cultivation on 5 g·L
-1
acetate added medium caused a similar K4 CPS produc-
tion (0.204 ± 0.01 g·L
-1) while on 10 g·L
-1 even a slightly
higher titre was observed (0.228 ± 0.02 g·L
-1). Further
increasing the acetate concentration in the medium
reduced μmax, the final biomass yield and, consequently,
the K4 CPS production that, at the highest acetate con-
centration tested (40 g·L
-1), decreased to 0.020 ± 0.009
g·L
-1 (Figure 2). In these cases the bacteria did not use
the whole initial amount of glycerol (residual concentra-
tion between 3.2 and 3.9 g·L
-1) and did not reach the
same biomass maximum value obtained in the conven-
tional medium. As already reported before [8], in all
shake flask experiments, K4 CPS concentration reached
the maximum after 24 hours of culture. Different experi-
ments tested the ability of E. coli K4 to grow on acetate
(from 1.5 to 20 g·L
-1) in glycerol free medium. Also in
this case the acetate addition did not cause any pH modi-
fication in the media. The bacteria metabolised acetate,
as visible in Table 1, and a residue of acetate was
observed at the end of the experiment only in case of the
highest initial concentration. The higher the acetate titre
was the greater the cell concentration achieved (passing
from 0.92 to 1.99 gcdw·L
-1), while growth rates quickly
diminished from 0.84 to 0.51 h
-1.
Batch experiments
Fermentation experiments were performed in batch con-
ditions on the conventional medium to investigate K4
CPS production, as previously described [8]. Glycerol and
acetate concentrations during growth are reported in
Figure 3. The glycerol consumption rate ranged between
1.1 and 1.4 g·L
-1·h
-1, while acetate was produced at 0.30 ±
0.02 g·L
-1·h
-1. Successively, in late stationary phase, acet-
ate slowly decreased with a consumption rate in the
range from 0.06 to 0.07 g·L
-1·h
-1.
Microfiltration experiments
Three different types of microfiltration experiments were
performed to study the influence of carbon source concen-
tration in the medium and of a good oxygenation on bac-
terial growth, on capsular polysaccharide production and
on acetate formation. The design of the feeding profiles
and of the aeration conditions was coupled with the in situ
product removal strategy. First of all, we investigated two
different feeding profiles to find the best one for both
growth and K4 CPS production. In all the experiments
identical batch and fed-batch conditions were set, the
Figure 1 Acetate inhibition in shake flasks. Effect of different
acetate concentration addition to the conventional medium on the
specific growth rates (μmax)o fE. coli K4 during exponential phase,
in shake flask conditions.
Figure 2 Effect of medium supplementation with acetate on
the production of K4 CPS. K4 CPS concentration and yield on
biomass, after 24 hours of growth, on conventional medium
supplemented with different acetate concentrations, in shake flask
conditions.
Table 1 E. coli K4 shake flask experiments on acetate
Initial acetate concentration (g·L
-1) 1.5 5 10 20
Final acetate concentration (g·L
-1) 0.031 0.38 0.98 5.25
Biomass (gcdw·L
-1) 0.92 1.57 1.98 1.99
μ max (h
-1) 0.84 0.69 0.64 0.51
E. coli K4 shake flask growth on 1.5, 5, 10, 20 g·L
-1 acetate media without
glycerol: initial and final acetate concentration, max biomass and max μ
values. All the standard deviations were less than 6%.
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tical feeding profiles were used up to 14 hours (see Materi-
als and Methods). After that, two different feeding rates,
were designed and tested in the MF experiments (Table 2).
In MF A profile, the feed rate of glycerol, supplied to the
culture, reached a maximum value of 4.5 g·L
-1·h
-1. As visi-
ble in the graph (Figure 4-MF A), all the glycerol fed (total
amount 231.5 g) was consumed by the bacteria without
accumulation and a maximum biomass concentration of
23.92 ± 0.72 gcdw·L
-1, with a corresponding yield of 0.186 ±
0.005 gcdw·g
-1, was obtained. The final K4 CPS concentra-
tion in the culture supernatant was 2.03 ± 0.08 g·L
-1
(Table 3). The microfiltration modules were able to refresh
the medium keeping an acetate concentration inside
the vessel lower than 5 g·L
-1 up to 24 hours of culture;
then the increasing amount of acetate (final concentration
> 10 g·L
-1) decelerated growth toward an initial stationary
phase and lowered the K4 CPS production. In order to
further enhance the capsular polysaccharide production, a
higher glycerol feeding rate was used for the MF B experi-
ment and improved aeration conditions were supplied sus-
taining the bacterial cell respiration (Table 2). The bacterial
cells perfectly adapted their metabolism to the set profile,
thus prolonging the growth phase up to 42 hours (Figure
4-MF B). The culture reached a higher maximum biomass
Figure 3 Batch experiments. E. coli K4 batch experiments: growth,
glycerol consumption, acetate production and re-consumption.
Table 2 Microfiltration experiment parameters
MF A MF B MF C
Stirring (rpm) 250-600 250-1000 250-800
Aeration (L·min
-1) 1.0-1.4 1.0-1.8 1.0-1.6
pO2 setting (% DO) 20 20 20-40
Feeding profile MF phase (g·L
-1·h
-1)
12-24 hours 2.7® 4.5 2.7® 5.4 2.7® 5.4
24-to the end 4.5® 3.2 5.4® 4.6 5.4® 4.6
Total glycerol fed (g) 236.5 291.8 325.3
Total glycerol consumed (g) 231.9 289.7 320.0
E. coli K4 three different MF experiments: Stirring, aeration and pO2 setting
parameters; feeding profiles in MF phase, total glycerol fed and consumed.
Figure 4 Microfiltration experiments. E. coli K4 three different MF
experiments: growth, glycerol consumption, acetate and K4 CPS
production. The arrows indicate the starting points of fed-batch
phase (FB), microfiltration phase (MF) and of the eventual increase
of the pO2 setting (pO2 40%).
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-1) and higher biomass
yield (Yx/s= 0.197 ± 0.008 gcdw·g
-1), compared to the MF A
results. The final acetate in the vessel was about 10 g·L
-1
after 40 hours of growth and the bacteria produced 3.00 ±
0.12 g·L
-1 of K4 CPS (Table 3). In MF B almost the whole
amount of glycerol fed to the culture was consumed by the
bacteria (291.8 g glycerol fed versus 289.7 g glycerol con-
sumed). Further increasing the glycerol feeding rate did
not improve K4 CPS production (data not shown). Once
the feeding profile was optimized, the pO2 setting was var-
ied in order to study the effect of a higher oxygen concen-
tration on growth and K4 CPS production. A third type of
experiment (Figure 4- MF C) was conducted using the
same optimised feeding profile of MF B (Table 2) but the
dissolved oxygen (DO) lower limit was increased from 20%
to 40% soon after 15 hours of growth. In this way the acet-
ate formation was limited and its concentration always
kept below 6 g·L
-1 inside the vessel. As a consequence of
that a higher maximum biomass concentration and bio-
mass yield on substrate were reached (36.4 ± 1.5 gcdw·L
-1
and 0.204 ± 0.008 gcdw·g
-1), compared with the previous
results, and a final K4 CPS concentration in the culture
s u p e r n a t a n to f4 . 3 3±0 . 1 7g · L
-1 was obtained (Table 3).
A further increase of oxygen in the vessel, setting the pO2
value at 70%, did not support the growth and the capsular
polysaccharide production in the same way (the maximum
biomass reached was 27.4 gcdw·L
-1 and the final total K4
CPS concentration was 2.33 g·L
-1). A certain stress effect
was noted and, already after 19 hours of growth, the viabi-
lity of the bacterial cells resulted diminished of almost 40%
compared with the one obtained in MF C fermentation
(data not shown). During MF experiments the K4 CPS pro-
duced and released in the medium was partly found in the
permeates (Figure 5). The whole amount of capsular
polysaccharide in all the permeates, at the end of each
experiment, was determined and the exact final total K4
CPS concentration was calculated (Table 3); thus the pre-
cise yields of K4 CPS on biomass and on substrate as well
as the productivity values were re-calculated (Table 3). The
percentage of the capsular polysaccharide found in the
permeates varied according to the experiment; the higher
the K4 CPS amount in the culture supernatant, the lower
the one found in the microfiltrated volumes (Figure 6).
Discussion
Glycosaminoglycans are high value molecules, with a
wide range of biomedical applications. In the last decade
new biotechnological productive processes to obtain
GAGs have been studied in order to avoid the tradi-
tional, long and unsafe extractive procedures from ani-
mal tissues. Hyaluronic acid has been produced
commercially since the early 1980 s using Streptococcus
equi subsp. equi and subsp. zooepidemicus or genetically
modified strains [6]. Biotechnological chondroitin
Figure 5 Capillary electrophoresis analysis of K4 CPS in
microfiltration supernatants and permeates. Overlaid
electropherograms of E. coli K4 CPS in the MF broth supernatants
(black trace) and in the permeates (blue trace).
Table 3 Microfiltration experiment results
MF A MF B MF C
Time (h) 42 42 46
Maximal biomass concentration (gcdw·L
-1) 23.90 31.70 36.40
μFB phase (h
-1) 0.21 0.21 0.21
μMF phase (h
-1) 0.10 0.13 0.12
Overall YX/Glycerol (gcdw·g
-1) 0.186 0.197 0.204
Culture supernatant K4 CPS concentration
(gK4CPS·L
-1)
2.03 3.00 4.33
Total K4 CPS produced (gK4CPS·L
-1) 2.73 3.43 4.73
Overall YK4 CPS/Glycerol (gK4CPS·g
-1) 0.021 0.022 0.027
YK4 CPS/X (gK4CPS·gcdw
-1) 0.067 0.108 0.130
Productivity K4 CPS (gK4CPS·L
-1·h
-1) 0.065 0.082 0.103
JMF 12-24 h [L·(m
2·h)
-1] 1.71 1.62 1.63
JMF 25h-end [L·(m
2·h)
-1] 0.88 1.1 0.91
Permeate total volume (L) 5.60 6.50 6.10
Exchanged volumes (L·L
-1) 3.10 3.60 3.40
Parameters and data obtained from the E. coli K4 three different MF
experiments. All the standard deviations were less than 5%.
Figure 6 K4 CPS presence in microfiltration supernatants and
permeates. E. coli K4 three different MF experiments: the ratio, in
percentage, between the K4 CPS amounts (g) present in the
supernatants or in the permeates on the total amount (g) of K4 CPS
produced, at the end of the growth. All the standard deviations are
less than 6%.
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ket. In a previous paper we investigated the possibility
to set up a biotechnological process for the production
of chondroitin, starting from a structural related capsu-
lar polysaccharide (K4 CPS) produced by E. coli O5:K4:
H4 [8]. In particular, a K4 CPS concentration of 1.4 g·L
-
1 was reached in fed-batch fermentation but a further
increase in biomass and capsular polysaccharide produc-
tion was probably limited by organic acid formation.
Acetate accumulation is one of the main constraints in
E. coli fermentations; this growth inhibiting metabolite
is produced in excess of substrate or in conditions of
oxygen limitation. Different strategies are described in
literature to limit its synthesis: genetic approaches var-
iously modified the central metabolism of E. coli,a l t e r -
ing the glucose uptake mechanism or the tricarboxylic
acid pathways. The optimization of the media and the
study of the oxygen consumption are tools generally
used in the bioprocess approaches [10]. Glycerol is
widely used as carbon source, instead of glucose,
because of its low transport rate into the cell that helps
in slowing the flux of carbon through the glycolysis thus
reducing the acetate production [9]. Insufflating oxygen-
enriched air could be a solution to avoid anaerobic con-
ditions of growth, while the employment of pH-stat or
substrate limited feeding profiles could control acetate
formation but also reduce the bacterial cell growth rate.
Dialysis and macro porous ion-exchange resin based fer-
mentors have been widely employed in order to obtain
high cell density cultivations of E. coli, limiting acetate
inhibition and, at the same time, avoiding the drawbacks
of low growth rate feeding methods [11-13]. Recently
high cell density cultivations of E. coli for the produc-
tion of recombinant proteins were performed in rock-
ing-motion-type bioreactor [16].
A dialysis bioreactor has been used also for the growth
of the capsulated strain E. coli K12 but the study
focused on the biomass formation and not on the poly-
saccharide production [17]. The inhibiting effect of acet-
ate on E. coli K4 growth rate could be a problem in the
designing of a high cell density cultivation process for
the production of the chondroitin-like capsular polysac-
charide. Although the capsular polysaccharide constitu-
tes part of the cell wall and could be considered a
biomass related product, its biosynthesis is influenced
by nutritional, environmental and cultivation conditions
[7,8]. For these reasons we first investigated, in shake
flask experiments, the effect of acetate, added to the
conventional medium, and its influence on both bacter-
i a lc e l lg r o w t ha n dK 4C P Sp r o d u c t i o n .O u rd a t a
showed that acetate concentrations higher than 5 g·L
-1
negatively influenced E. coli K4 growth rates, while K4
CPS production is positively affected up to 10 g·L
-1 acet-
ate supplementation and progressively reduced by
higher concentration addition (Figure 2). An acetate
concentration higher than 5 g·L
-1 is commonly consid-
ered an inhibiting threshold for E. coli genus, because it
reduces growth rates and biomass yield [18]; De May
and co-worker even reported a decrease of growth and
of recombinant protein production above 1 g·L
-1 [10].
E. coli K4 showed the same behaviour, although a higher
tolerance for the acetate presence in the medium, up to
10 g·L
-1, was observed. This higher adaptability could
probably be related to the presence of the capsular poly-
saccharide that has a role of cell protective layer in var-
ious stressful conditions [19]. On the other hand, as
reported for other strains of the same genus [20], also
E. coli K4 seemed to be capable to metabolise acetate,
growing in shake flask experiments on a medium con-
taining up to 20 g·L
-1 acetate (Table 1). E. coli K4 meta-
bolised acetate also in batch experiments: in the
stationary phase, when glycerol was exhausted, the bac-
terial cells started to re-consume the produced acetate
with a rate similar to the ones reported for other E. coli
strains [21]. Although the cells can use acetate, prolong-
ing the growth resulted not convenient. In batch, the
maximum of K4 CPS titre is usually reached in
24 hours [8] and after that time lysis of the bacterial
cells occurrs. These data were taken into consideration
to set up and optimise the microfiltration experiments
in which a balance was sought between keeping growth
rates high to improve K4 CPS productivity and not
accumulating acetate beyond the critical threshold (in
our case between 5-10 g·L
-1). Placing microfiltration
modules in the bioreactor the exhaust medium could be
removed from the vessel, while the cells were kept
inside in a controlled environment. Three different types
of experiments in microfiltration were run as described
in the Material and Methods section. In MF A experi-
ments a first feeding profile w a st e s t e da n d ,a tt h ee n d
of the growth, a K4 CPS concentration 1.5-fold higher
than the one previously reported for the fed-batch
experiments was obtained [8]. In MF B experiments,
instead, the use of a higher feeding profile, coupled with
higher aeration rates and a medium exchange of 3.6
volumes, allowed to keep the acetate concentration in
the vessel below 5 g·L
-1 for a longer time respect to MF
A. In these conditions the bacteria produced 2.1-fold
higher K4 CPS titre, without any glycerol accumulation.
This feeding profile was considered the optimal one for
our purposes and used also in MF C experiments. In
this case O2 enrichment was provided to keep up with
the strain’s oxygen demand, without further pushing the
airflow and the stirring rates that easily caused mechani-
cal cell stress and foam formation. The oxygen setting
up at 40%, after 15 hours of growth, together with the
medium exchange, assured better metabolic conditions
than in MF B experiments, thus maintaining the acetate
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-1 up to the end of the experi-
ment. As a result, this increase in oxygen availability
permitted the achievement of a higher maximum bio-
mass concentration and biomass yield on substrate as
well as the highest K4 CPS titre ever obtained (4.33 ±
0.17 g·L
-1) (Table 3). As reported before for the MF
experiments of exopolysaccharide producing lactic acid
strains [15], part of the K4 CPS, produced by the cells
and then released in the medium during the fermenta-
tion, was eluted in the microfiltrated volumes. Although
the MF capillaries have a cut-off of 0.22 μm, not all the
K4 CPS produced was found in the permeates and the
percentage of eluted capsular polysaccharide seemed to
depend on the polysaccharide concentrations in the cul-
ture supernatant (Figure 5 and 6). Certainly cellular
cake depositions, that became thicker as the cell density
grew, contributed to the K4 CPS retention inside the
vessel, together with a polysaccharide gel layer forma-
tion. In particular, in MF B and C the higher K4 CPS
concentrations in the supernatants, respect to MF A,
contributed to module surfaces fouling and reduced by
half the flow-through of capsular polysaccharide in the
microfiltrated volumes. Considering also the amount of
K4 CPS in the permeates, the exact final total capsular
polysaccharide production, yields and productivities for
each type of experiment were re-calculated. In all the
MF experiments higher values, than those previously
reported, were obtained [8]; in particular, in the MF C,
the highest K4 CPS concentration, so far obtained, was
produced (4.73 ± 0.20 g·L
-1), corresponding to an
amount almost 16-fold and 3.33-fold higher than the
ones obtained using batch and fed-batch techniques,
respectively [8].
Conclusions
Acetate concentration proved to affect bacterial cell
growth and K4 CPS production. All the results of fer-
mentation experiments confirmed the consistency of the
microfiltration bioreactor technology as a valid tool in
the biotechnological production of the chondroitin pre-
cursor, the E. coli K4 capsular polysaccharide. In the fra-
mework of this research we addressed the issue of the
low yields reported for the microbial production of K4
CPS [22], permitting the achievement of titres similar to
the ones obtained in the biotechnological production of
the most noted glycosaminoglycan, that is hyaluronic
acid [23].
Materials and methods
Materials
All the growth medium components, salts and the anti-
foam agent were supplied by Sigma-Aldrich (USA).
Neutralised soya peptone was furnished by OXOID
(United Kingdom), while ammonium hydroxide,
sulphuric acid and phosphoric acid were purchased by
Carlo Erba (Italy). Salts, acid or alkali components,
needed to prepare buffers for capillary electrophoresis,
for high pressure liquid chromatography and anion
exchange chromatography analyses were by Sigma-
Aldrich (USA).
Bacterial strain
The strain E. coli O5:K4:H4 (U1-41,11307) was pur-
chased from the Culture Collection of the University of
Göteborg (Sweden). The strain was stored and main-
tained in 20% (v/v) glycerol stock solutions at T= -80°C.
The growth medium used was the same described in a
previous paper [8]; [Conventional medium composition:
glycerol (10 g·L
-1), soya peptone (1 g·L
-1), KH2PO4
(2 g·L
-1), K2HPO4 (9.7 g·L
-1), sodium citrate dehydrate
(0.5 g·L
-1), (NH4)2SO4 (1 g·L
-1), MgCl2 (0.1 g·L
-1)]. This
medium was used in shake-flask experiments after being
sterilized in autoclave: in acetate inhibiting threshold
tests acetate was added to the conventional medium, in
acetate metabolising tests acetate was added to the
glycerol depleted medium. Medium in situ sterilization
was used for fermentation experiments. In all cases,
K2HPO4 was added to the sterilized media as a concen-
trated solution (388 g·L
-1) after sterilization by filtration
with 0.22 μm membranes (Millipore, France).
Shaking flask experiments
The acetate inhibiting threshold for E. coli K4 growth
was investigated during shake flask experiments. Vari-
able volumes of a 3.4 M acetate stock solution were
added to the conventional medium, at the beginning of
the growth, in order to obtain the desired final acetate
concentration (0, 1.5, 5, 10, 15, 20, 30 and 40 g·L
-1).
Small aliquots (2 mL) of the growth medium, after acet-
ate addition, were withdrawn to measure the initial
medium pH by using a pH-meter (Cyberscan 510,
Eutech Instruments, Thermo Fisher Scientific Inc.). For
every single acetate concentration, three independent
experiments were performed using 1 L Erlenmeyer
flasks, equipped with four baffles and containing
200 mL of medium, in a rotary air shaker (model
Minitron, Infors, Switzerland) with a rotation speed of
200 rpm at the optimal growth temperature of 37°C.
Glycerol stock preparations of E. coli K4 were used to
inoculate the media. Samples of broth were collected at
time intervals of 1 hour, up to 24 hours of growth, to
measure the absorbance at 600 nm (Spectrophotometer
DU800, Beckman Coulter, USA). Biomass dry weight
was measured during cultivations: variable volumes (2-5
ml) of cultures were filtered on a 0.22 μmp r o p y l e n e
membrane, the pellet deposited on the microfilter was
then washed with a volume of physiological saline solu-
tion and successively the membrane was placed in an
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Cell dry weight values were then calculated and corre-
lated in a plot to the absorbance measurements.
E. coli K4 growth rates (μ) in the different media were
calculated during the exponential phase (from 0 to
3 hours) with a linear regression method as averaged
values of three experiments. After 24 hours of culture,
samples of supernatant were withdrawn to evaluate also
the average K4 CPS concentration in the different
growth conditions. A E. coli K4 growth on the complete
conventional medium was performed every time as
control.
Further shake flask experiments were performed to
test the strain ability to metabolise acetate; variable
volumes of the 3.4 M acetate stock solution were added,
at the beginning of the growth, to the conventional
medium, depleted of glycerol, in order to obtain an
initial acetate concentration of 1.5, 5, 10 or 20 g·L
-1.
Growths were performed, as already described above, in
triplicate; initial pH was checked, biomass formation
w a sf o l l o w e db ym e a s u r i n gt h ea b s o r b a n c ea t6 0 0n m
up to 24 hours of culture and cell dry weight values
were obtained as described above. Growth rates (μ)
were calculated during the exponential phase (from 0 to
3 hours). Sample of supernatant were withdrawn to ana-
lyse the acetate concentrations in the media at initial
and final time.
Fermentors
A Biostat CT fermentor, (Braun Biotech International,
Sartorius Group, Germany), in situ sterilizable, with a
total volume of 2.5 L and a working one of 2 L was
used to perform batch and microfiltration experiments.
The system was equipped with pH, temperature and
pO2 probes and four peristaltic pumps for the addition
of alkali, acid, nutrients, salts or antifoam solutions. All
the fermentation parameter data were registered by a
Digital Control Unit (DCU) during the whole experi-
ments, while a computer connected to the fermentor,
equipped with a MFCS-win software, was used to remo-
tely control all the fermentation parameters, included
pH, pO2, agitation speed (rpm) and aeration (L·min
-1)
and for data storage. The pO2 electrode (Mettler
Toledo, Switzerland) was calibrated using a pure oxygen
flow as 100% value. During the fermentation process the
pO2 inside the vessel was kept always higher than a phy-
siological suitable value (20%) exploiting a “Gasmix” sys-
tem able to enrich the air flux with pure O2 pulses.
During the experiments the optimal pH value was kept
constant at 7.5 by addition of 30% (v/v) NH4OH and or
30% (v/v) H2SO4 solutions through the pumps. In order
to perform the microfiltration experiments two microfil-
tration modules were fixed vertically in the vessel, next
to the baffles. The position of the modules was selected
to maximize turbulence near the filtering surface thus
reducing fouling occurrence [14,24]. A peristaltic pump
(313U model, Watson Marlow, United Kingdom) was
connected with the upper part of the module. If
switched on, it produced a pressure between the inner
and the outer side of the capillaries, thus driving a
trans-membrane flux and the consequent removal of the
exhaust medium while keeping the cells in optimal con-
ditions inside the reactor.
Batch experiments
Batch fermentations were performed, as previously
described [8], using a shaking flask culture as inoculum.
The bacterial growth was followed by measuring the
absorbance at 600 nm and samples of supernatant were
withdrawn during the experiments to analyse glycerol
and acetate concentration in the broth. Glycerol con-
sumption rate and acetate production and re-consump-
tion rates were calculated.
Microfiltration experiments
Three different types of microfiltration experiments (MF
A, MF B, MF C) were performed at 37°C and at a pH of
7.5, with a starting medium volume of 1.8 L. A shaking
flask culture was used as inoculum. The experiments
lasted about 42-46 hours and consisted in three distinct
phases: batch, fed-batch and microfiltration. After 7 hours
of growth in batch mode, the fed-batch phase started by
feeding the culture with a concentrated medium solution,
containing 200 g·L
-1 of glycerol and 20 g·L
-1 of soya pep-
tone, and initially using an exponential profile designed
according to Keller and Dunn [25]. Successively (e.g. after
5 h of fed-batch) a linear profile was used towards a
constant feeding rate calculated on the base of the
consumption rate measured in previous experiments.
The feeding rates were modulated in order to keep the
glycerol concentration in the broth always above 0.3 g·L
-1.
After 5 hours of fed-batch phase, at 12 hours of growth,
the MF phase was started switching on the pump, con-
nected with the modules, at a fixed set value of 30%. A
total volume of exhaust medium in the range from 5.60 to
6.50 L, corresponding to about 3-folds of the initial culture
volume, was exchanged during the microfiltration experi-
ments; the permeates, coming from the microfiltration of
the broth carried out by the modules, were collected. To
improve the medium exchange efficiency, back-flushings
of the modules were executed every hour, by simply
inverting the pump flux for 1-2 minutes, using a sterilized
fresh salt solution as cleaning solution. Starting from the
beginning of the MF phase, a different feed, containing
420 g·L
-1 of glycerol and 42 g·L
-1 of soya peptone, was
added to the medium. The three cultures were supplied
with the same feeding profile up to 14 hours; starting from
this time two different feeding profiles were designed and
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fermentation, a 100-fold diluted antifoam solution (Anti-
foam 204, Sigma-Aldrich, USA) was added automatically
to the culture in case of high and dense foam presence.
The microorganism oxygen demand was met increasing
the starting stirring value from 250 to 600 rpm (MF A), to
1000 rpm (MF B) or to 800 rpm (MF C). Aeration was set
in a range of values varying from a minimum of 0.55 to a
maximum of 0.77 vvm (MF A), of 1.00 vvm (MF B) or of
0.88 vvm (MF C). The pO2 parameter was set above the
20% of dissolved oxygen for all the duration of the experi-
ments, except for the MF C case in which the pO2 was
kept above 40% after 15 hours of growth by increasing the
airflow first and then, eventually, insufflating pure O2
spikes into the vessel. All the experiments were stopped
after more than 40 hours of growth and only when a pro-
longed stationary phase occurred. The kinetics of growth
were evaluated by a spectrophotometer determination of
the absorbance at 600 nm of culture broth samples, with-
drawn at different times during the process (Spectrophot-
ometer DU800, Beckman Coulter, USA) and by cell dry
weight values, obtained as previously described. Further-
more, during the experiments, samples of broth were col-
lected also to evaluate the glycerol consumption, the
bacterial K4 CPS and organic acids production. Samples of
permeates were also withdrawn to determine the concen-
tration of K4 polysaccharide in the microfiltrated volumes.
The growth and production rates as well as the productiv-
ity were calculated for each type of experiment; the results
are average values from three replicates.
Analytical Methods
Sample preparation and quantification of glycerol and
organic acids
Samples of 24 hour shake flask cultures or of MF fermen-
tation broth, at different times of growth, were collected
and centrifuged at 1700 × g (Avanti J-20 XP, Beckman
Coulter, USA) in order to separate the biomass and
recover the supernatants; samples of permeates, collected
during MF experiments, were not centrifuged, not pre-
senting cell debris. In all cases, the samples (2 mL) were
then ultrafiltered/diafiltered on 10 KDa centrifugal filter
devices (YM-10 Centricon, Amicon, USA) at 5000 × g and
concentrated 10 folds. Filtrates were analyzed by an
HPAE-PAD ionic chromatographic system (model ICS-
3000, Dionex, USA) to quantify the residual glycerol and
by HPLC system (model STH 575, Dionex, USA) to mea-
sure the organic acids produced, as previously reported
[8]. In case of acetate inhibiting threshold tests and MF
experiments, the retentate, containing the K4 CPS, was
analyzed by capillary electrophoresis.
Capsular polysaccharide determination
The K4 CPS concentration was determined by capillary
electrophoresis analysis performed on a P/ACE MDQ
instrument (Beckman Coulter, USA), according to the
previously described method [26]. In case of acetate
inhibiting threshold shake flask experiments, the K4
CPS concentration was analysed after 24 hours of
growth; while during MF fermentations the K4 polysac-
charide concentration was determined in both broth
supernatant and in permeate samples, withdrawn at dif-
ferent times. In case of MF experiments the analyses
allowed to build curves of the K4 CPS concentration
present in the vessel (in the culture supernatant), show-
ing the kinetics of the capsular polysaccharide produc-
tion and release. Furthermore, using the data coming
from the permeates, the total concentration of K4 CPS
produced was calculated as the total sum of the culture
supernatant and permeate K4 CPS amounts, in terms of
grams, divided by the internal, constant broth volume.
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